NEVIRAPINA AUROVITAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
NEVIRAPINA AUROVITAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Pending
Register Number
85896
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Apr 8, 2021
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number85896
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
NEVIRAPINAActive
Quantity: 400 mg
Name: NEVIRAPINA
ATC CLASSIFICATION (3)
J05A
J05AG
J05AG01